pentoxifylline has been researched along with Pneumonia in 11 studies
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a TNFα inhibitor known to suppress inflammation." | 5.40 | Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation. ( Cervelli, JA; Gow, AJ; Hall, L; Laskin, DL; Laskin, JD; Malaviya, R; Massa, CB; Sunil, VR; Vayas, KN, 2014) |
| "These results indicate that meconium aspiration induces severe inflammation in the lung." | 5.38 | The effects of pentoxifylline on lung inflammation in a rat model of meconium aspiration syndrome. ( Atıcı, A; Helvacı, İ; Muşlu, N; Polat, A; Turhan, AH, 2012) |
| "Pentoxifylline (PTX) has been shown to attenuate neutrophil activation and end-organ injury in shock states such as hemorrhage and sepsis." | 5.35 | Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. ( Coimbra, R; de Campos, T; Deree, J; Loomis, WH; Martins, JO; Putnam, JG; Shenvi, E, 2008) |
| "Pentoxifylline (PTX) has been shown to reduce sepsis-induced neutrophil sequestration in the lung and inhibit endotoxin-mediated release of tumor necrosis factor-alpha (TNF-alpha)." | 2.68 | Pentoxifylline does not alter the response to inhaled grain dust. ( Jagielo, PJ; Knapp, HR; Quinn, TJ; Schwartz, DA; Watt, JL, 1997) |
| "Counterproductive lung inflammation and dysregulated thrombosis contribute importantly to the lethality of advanced COVID-19." | 1.56 | Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole. ( Barroso-Aranda, J; DiNicolantonio, JJ, 2020) |
| "Pentoxifylline is a TNFα inhibitor known to suppress inflammation." | 1.40 | Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation. ( Cervelli, JA; Gow, AJ; Hall, L; Laskin, DL; Laskin, JD; Malaviya, R; Massa, CB; Sunil, VR; Vayas, KN, 2014) |
| "Pentoxifylline (PTX) has been shown to exert anti-inflammatory effects in experimental acute lung injury." | 1.39 | Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent. ( Konrad, FM; Neudeck, G; Ngamsri, KC; Reutershan, J; Thiel, M; Vollmer, I, 2013) |
| "These results indicate that meconium aspiration induces severe inflammation in the lung." | 1.38 | The effects of pentoxifylline on lung inflammation in a rat model of meconium aspiration syndrome. ( Atıcı, A; Helvacı, İ; Muşlu, N; Polat, A; Turhan, AH, 2012) |
| "Pentoxifylline (PTX) has been shown to attenuate neutrophil activation and end-organ injury in shock states such as hemorrhage and sepsis." | 1.35 | Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. ( Coimbra, R; de Campos, T; Deree, J; Loomis, WH; Martins, JO; Putnam, JG; Shenvi, E, 2008) |
| "Pentoxifylline was effective in reducing inflammatory lung injury associated with high tidal volume ventilation." | 1.35 | The effect of pentoxifylline on the pulmonary response to high tidal volume ventilation in rats. ( Bancalari, E; Devia, C; Hehre, D; Lessa, A; Suguihara, C; Xianyu, S, 2008) |
| "Pentoxifylline-treated animals had lower levels of lysozyme (p < ." | 1.29 | Effects of pentoxifylline on in vivo leukocyte function and clearance of group B streptococci from preterm rabbit lungs. ( Aeberhard, EE; Gilliam, MB; Mah, MP; Sherman, MP, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| DiNicolantonio, JJ | 1 |
| Barroso-Aranda, J | 1 |
| Konrad, FM | 1 |
| Neudeck, G | 1 |
| Vollmer, I | 1 |
| Ngamsri, KC | 1 |
| Thiel, M | 1 |
| Reutershan, J | 1 |
| Sunil, VR | 1 |
| Vayas, KN | 1 |
| Cervelli, JA | 1 |
| Malaviya, R | 1 |
| Hall, L | 1 |
| Massa, CB | 1 |
| Gow, AJ | 1 |
| Laskin, JD | 1 |
| Laskin, DL | 1 |
| de Campos, T | 1 |
| Deree, J | 1 |
| Martins, JO | 1 |
| Loomis, WH | 1 |
| Shenvi, E | 1 |
| Putnam, JG | 1 |
| Coimbra, R | 1 |
| Turhan, AH | 1 |
| Atıcı, A | 1 |
| Muşlu, N | 1 |
| Polat, A | 1 |
| Helvacı, İ | 1 |
| Lessa, A | 1 |
| Suguihara, C | 1 |
| Xianyu, S | 1 |
| Hehre, D | 1 |
| Devia, C | 1 |
| Bancalari, E | 1 |
| Mah, MP | 1 |
| Aeberhard, EE | 1 |
| Gilliam, MB | 1 |
| Sherman, MP | 1 |
| Jagielo, PJ | 1 |
| Watt, JL | 1 |
| Quinn, TJ | 1 |
| Knapp, HR | 1 |
| Schwartz, DA | 1 |
| Konstan, MW | 1 |
| Thorne, PS | 1 |
| McCray, PB | 1 |
| Howe, TS | 1 |
| O'Neill, MA | 1 |
| Goffin, J | 1 |
| Kreisman, H | 1 |
| Sandor, V | 1 |
1 review available for pentoxifylline and Pneumonia
| Article | Year |
|---|---|
Treatment of airway inflammation in cystic fibrosis.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Anti-Inf | 1996 |
1 trial available for pentoxifylline and Pneumonia
| Article | Year |
|---|---|
Pentoxifylline does not alter the response to inhaled grain dust.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Bronchial Hyperreactivity; Bronchoalveolar La | 1997 |
9 other studies available for pentoxifylline and Pneumonia
| Article | Year |
|---|---|
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
Topics: Adenosine A2 Receptor Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; C | 2020 |
Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Humans; Immunohistochemistry; | 2013 |
Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation.
Topics: Acute Lung Injury; Animals; Chemical Warfare Agents; Cyclooxygenase 2; Heme Oxygenase-1; Irritants; | 2014 |
Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Chemokine CXCL1; Disease Models, Animal; | 2008 |
The effects of pentoxifylline on lung inflammation in a rat model of meconium aspiration syndrome.
Topics: Animals; Arteries; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Infant, Newborn; Lu | 2012 |
The effect of pentoxifylline on the pulmonary response to high tidal volume ventilation in rats.
Topics: Animals; Bronchoalveolar Lavage Fluid; Female; Inflammation Mediators; Lung; Pentoxifylline; Peroxid | 2008 |
Effects of pentoxifylline on in vivo leukocyte function and clearance of group B streptococci from preterm rabbit lungs.
Topics: Animals; Animals, Newborn; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Disease Models, An | 1993 |
Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation.
Topics: Adenoviridae; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalv | 1999 |
Bleomycin-induced lung toxicity and pentoxifylline.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Enzyme I | 2001 |